Validation of FDG-PET Segmentation Tools for Tumor Delineation by Correlation of CT- and FDG-PET Volume Measurements With Histopathology of Nodal Metastases of Head and Neck Carcinomas.
N/A
18 Years
N/A
18 Years
N/A
Open (Enrolling)
Both
Head and Neck Cancer
Both
Head and Neck Cancer
Trial Information
Validation of FDG-PET Segmentation Tools for Tumor Delineation by Correlation of CT- and FDG-PET Volume Measurements With Histopathology of Nodal Metastases of Head and Neck Carcinomas.
Inclusion Criteria:
- All patients with N+ squamous cell carcinoma of the head and neck, planned for neck
dissection.
- Age >18 years.
Exclusion Criteria:
- Pregnancy.
- Women breast feeding
Type of Study:
Observational
Study Design:
N/A
Outcome Measure:
How accurate are the various FDG-PET segmentation tools?
Outcome Time Frame:
Measurements are performed in conjunction with the clinical pathologist directly postoperatively.
Safety Issue:
No
Authority:
Netherlands: The Central Committee on Research Involving Human Subjects (CCMO)
Study ID:
2008/060
NCT ID:
NCT00782691
Start Date:
July 2008
Completion Date:
Related Keywords:
- Head and Neck Cancer
- FDG-PET segmentation tools
- Head-and-neck cancer
- Histological validation
- Carcinoma
- Head and Neck Neoplasms
- Neoplasm Metastasis
- Carcinoma, Squamous Cell
Name | Location |
|---|
